English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Shire
Kacie Whaley
| Sep 1, 2017
Rare disease therapy company, Shire, making executive changes
Marian Johns
| Aug 29, 2017
Shire, MircoHealth partner on app for hemophilia patients
Nicholas Gueguen
| Aug 1, 2017
Immunodeficiency disease patients report higher quality of life with CUVITRU treatment
Erianne Leatherman
| May 22, 2017
Shire outlines ADHD research at American Psychiatric Association meeting
Robert Hadley
| Apr 7, 2017
FDA accelerates review for drug that treats blood-clotting disease
Gene Johnson
| Mar 5, 2017
Shire honors Rare Disease Day with launch of 'Rare Count'
Keri Carbaugh
| Feb 17, 2017
Shire provides latest data on Hunter's syndrome, Gaucher disease
Keri Carbaugh
| Jan 8, 2017
Shire names Clark non-executive director
Trending
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
Patient Daily
| Sep 19, 2025
ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’
